Showing results (71-80 of 144) with videos related to
Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancerHedy L Kindler, Gregory Friberg, Deepti A Singh, et al.Journal for Immunotherapy of Cancer|May 16, 2014
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinomaDaniel M Geynisman, Yuanyuan Zha, Rangesh Kunnavakkam, et al.Blood Cancer Journal|May 29, 2024
Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplantBenjamin A Derman, Jennifer Cooperrider, Jacalyn Rosenblatt, et al.Cancer Research|November 20, 2002
Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinomaS Diane Yamada, Jonathan A Hickson, Yancey Hrobowski, et al.Journal of Visualized Experiments : Jove|February 10, 2011
Generation of comprehensive thoracic oncology database--tool for translational researchMosmi Surati, Matthew Robinson, Suvobroto Nandi, et al.Cancer|April 21, 2021
A prospective clinical and transcriptomic feasibility study of oral-only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidityBenjamin E Onderdonk, Paige L Dorn, Carlos Martinez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate CancerAnthony V Serritella, Daniel Shevrin, Elisabeth I Heath, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2004
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecanFederico Innocenti, Samir D Undevia, Lalitha Iyer, et al.Oncogene|April 13, 2004
Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumorsKarin Schreiber, Ronald E Cannon, Theodore Karrison, et al.Scientia Medica|May 12, 2012
Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis StudyA Gwendolyn Noble, Paul Latkany, Jaroslaw Kusmierczyk, et al.Pageof 15